Target
Interleukin-17F
Ligand
BDBM617582
Substrate
n/a
Meas. Tech.
AlphaLISA Assay
IC50
63.1±n/a nM
Citation
 MARTIN, BPWESTERMANN, JKERN, OTHOLMES, AJMORRISON, AKICZUN, MAL MASRI, MSMITH, AHUXLEY, A IL-17A MODULATORS US Patent  US20230286943 Publication Date 9/14/2023 
Target
Name:
Interleukin-17F
Synonyms:
Cytokine ML-1 | IL17F | IL17F_HUMAN | il-17f
Type:
Enzyme Catalytic Domain
Mol. Mass.:
18053.35
Organism:
Homo sapiens (Human)
Description:
Q96PD4
Residue:
163
Sequence:
MTVKTLHGPAMVKYLLLSILGLAFLSEAAARKIPKVGHTFFQKPESCPPVPGGSMKLDIGIINENQRVSMSRNIESRSTSPWNYTVTWDPNRYPSEVVQAQCRNLGCINAQGKEDISMNSVPIQQETLVVRRKHQGCSVSFQLEKVLVTVGCTCVTPVIHHVQ
  
Inhibitor
Name:
BDBM617582
Synonyms:
US20230286943, Example 50
Type:
Small organic molecule
Emp. Form.:
C24H30N6O3
Mol. Mass.:
450.5334
SMILES:
C[C@H]1CC[C@@H](CC1)[C@H](NC(=O)c1conc1C)C(=O)Nc1ccc(cn1)-c1c(C)cnn1C |r,wU:1.0,wD:7.8,4.3,(2,5.9,;2,4.36,;3.33,3.59,;3.33,2.05,;2,1.28,;.67,2.05,;.67,3.59,;2,-.26,;3.33,-1.03,;4.67,-.26,;4.67,1.28,;6,-1.03,;7.41,-.4,;8.44,-1.55,;7.67,-2.88,;6.16,-2.56,;5.02,-3.59,;.67,-1.03,;.67,-2.57,;-.67,-.26,;-2,-1.03,;-2,-2.57,;-3.33,-3.34,;-4.67,-2.57,;-4.67,-1.03,;-3.33,-.26,;-6,-3.34,;-6.16,-4.87,;-5.02,-5.9,;-7.67,-5.19,;-8.44,-3.86,;-7.41,-2.71,;-7.73,-1.21,)|
Structure:
Search PDB for entries with ligand similarity: